← All postsCategory

Science

4 posts in this category, sorted most recent first.

2 May 2026·7 min read
GLP-1 + alcohol: what the 2026 data says, what we know, what we don't
The semaglutide and tirzepatide effect on alcohol intake is real and well-documented. The mechanism is partly understood, the long-term safety data is thin, and the practical advice for users on the drug is more nuanced than 'one drink is fine.' What the 2026 SURMOUNT-OASIS and downstream trials add.
tirzepatide semaglutide alcohol mechanism
23 Apr 2026·5 min read
What Attia and Huberman actually say about GLP-1 dosing
The credentialed clinicians have covered GLP-1 drugs for years. Here is what they actually say, not the clickbait version.
attia huberman glp-1 authorities
23 Apr 2026·7 min read
Cold chain for peptides: what 2-8°C actually means for potency
Heat degrades peptides. But not all peptides, not at all temperatures, not at all durations. The honest version of the cold-chain question.
cold-chain peptide-storage glp-1 shipping
23 Apr 2026·5 min read
SURMOUNT-1 in plain English: what the trial actually showed
The tirzepatide weight-loss trial that reset the market. Here is what it tested, what it found, and the parts the press skipped.
surmount-1 tirzepatide clinical-trials nejm

Other categories

Buyer's guide 19 Evidence 15 Compound guide 7 Operations 6 Thailand Medical Tourism 4 Regulatory 3 Protocols 2 Comparisons 1 Longevity 1 Pricing 1 Safety 1 Thailand Th 1 Us Market 1 Vendor Trust 1